Olmesartan Medoxomil and Hydrochlorothiazide Tablets 20/12.5mg

Adult dose

This medication is administered once daily, one tablet, regardless of meals. Dosage should be adjusted every 2 to 4 weeks based on the patient's blood pressure response. Elderly patients should start with the lowest dose, and dosage adjustment should be made with caution considering renal function, cardiac function, coexisting diseases, and concomitant medications.

Child dose

The safety and efficacy for pediatric use have not been established.

This medication may cause serious harm to the fetus and newborn if taken during the second and third trimesters of pregnancy, so it should be discontinued immediately upon confirmation of pregnancy. Patients with allergies to the components of this medication, certain kidney or liver diseases, pregnant or breastfeeding women should not take this medication. This medication should be used cautiously in patients with low blood pressure or electrolyte imbalances, as well as those with certain heart or kidney diseases, and their condition should be monitored frequently during use. This medication can affect electrolyte balance in the body, so it is important to regularly check sodium, potassium levels, etc., through blood tests. Symptoms such as dizziness or low blood pressure may occur during treatment, so caution is advised while driving or operating hazardous machinery. This medication can interact with other drugs; therefore, particularly when taking potassium supplements, diuretics, lithium, or non-steroidal anti-inflammatory drugs, consultation with a physician is recommended. If any unusual skin reactions or severe allergic symptoms occur, discontinue use immediately and consult a healthcare professional. Women who are breastfeeding should consult a doctor before use, as this medication can be passed into breast milk and affect the infant. Safety and efficacy for pediatric use have not been established, so caution is required. In the case of overdose, symptoms such as low blood pressure, electrolyte abnormalities, dehydration may occur, and it is necessary to visit a medical institution immediately for appropriate treatment.

Serious side effects

Hives, severe swelling (edema), chest tightness, breathing difficulties, cold sweat, pallor, severe rash with high fever, blisters, skin peeling, pain in mucous membranes of mouth/eyes, shortness of breath or difficulty breathing, asthma attacks, respiratory issues accompanied by cough+fever, jaundice (yellowing of skin or eyes), extreme lethargy, sudden and severe headaches, thunderclap headache, seizures, confusion, visual disturbances, paralysis, urination changes

Mild side effects

• Nausea
• dizziness
• upper respiratory infection
• headache
• urinary tract infection
• abdominal pain
• dyspepsia
• gastroenteritis
• diarrhea
• elevated AST

This medication should be stored in a tightly closed container to prevent exposure to air or moisture, and it is best stored at room temperature between 1 and 25 degrees Celsius. Proper storage will maintain the drug's efficacy and prevent degradation.

Appearance

Light yellow round film-coated tablets

Package unit

30 tablets/bottle, 300 tablets/bottle